A bill awaiting introduction in the Senate would establish two new drug approval mechanisms for FDA.
Progressive and Exceptional approval, as they are named in the draft bill, would essentially codify existing FDA practices of allowing drugs in certain cases to
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?